In addition, DM itself or its associated treatments, such as angiotensin-converting enzyme (ACE) inhibitors, may influence the severity of COVID-19 by over-expressing the ACE2 receptor, a key entry point for the virus into cells​ [4]. The gene discussed is ACE; the disease is COVID-19.